Clinical Trial Update: A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2 study to assess the long-term health of adults who previously participated in a melanoma treatment trial, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Libtayo (cemiplimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Melanoma | Phase 2 | Status: ENROLLING_BY_INVITATION